Kelm, S., Gerlach, J., Brossmer, R., Danzer, C., & Nitschke, L. (2002). The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. Journal of experimental medicine, 195(9), . https://doi.org/10.1084/jem.20011783
Chicago-Zitierstil (17. Ausg.)Kelm, Sörge, Judith Gerlach, Reinhard Brossmer, Claus-Peter Danzer, und Lars Nitschke. "The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound." Journal of Experimental Medicine 195, no. 9 (2002). https://doi.org/10.1084/jem.20011783.
MLA-Zitierstil (9. Ausg.)Kelm, Sörge, et al. "The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound." Journal of Experimental Medicine, vol. 195, no. 9, 2002, https://doi.org/10.1084/jem.20011783.